在次要异常细胞学中HPV 16/18的敏感性差
(健康日) - 根据在线在线发布的荟萃分析,对人类乳头瘤病毒(HPV)16/18对患有次要异常细胞学的三元妇女的敏感性差。内科。
Marc Arbyn, M.D., from the Scientific Institute of Public Health in Brussels, and colleagues conducted a systematic literature review to examine the accuracy of genotyping for HPV types 16 and 18. Data were included for 24 moderate-to-good quality studies, involving 8,587 women with atypical squamous cells of undetermined significance (ASC-US) and 5,284 with low-grade squamous intraepithelial lesions (LSIL) who were triaged with tests for high-risk HPV (hrHPV) and HPV 16/18 to detect宫颈上皮内瘤形成(CIN)。
研究人员发现,对于患有ASC-US或LSIL的女性,HPV 16/18基因分型的汇集敏感性为CIN3 +约为70%。对于级别<2 cin的阈值,汇集特异性分别为ASC-US和LSIL的妇女分别为83和76%。在HPV 16/18阳性女性中,患有ASC-US和LSIL,CIN3 +的平均风险分别为17%和19%,HRHPV阳性的5%,但HPV 16/18负妇女患有ASC-US或LSIL。
“对患有次要异常细胞学的分类妇女进行HPV 16/18的检测是敏感的,但在HRHPV测试之后可能是有用的,如果女性为HPV 16/18阳性,则直接转诊,”作者写道。
一些作者披露了生物制药行业的财务关系。
进一步探索
版权所有©2016.健康天。版权所有。
用户评论